Need a business?

Fill out the form for our tailored recommendations, and we'll get in touch with you shortly.
About Us
Guangzhou Vbio Pharma Co., Ltd.

Guangzhou Vbio Pharma Co., Ltd. (here after as VBIO) is a certified high-tech enterprise and a global leader in human and animal reproductive biologics (including IVF and fertility) founded in 2015. Backed by elite protein biologics experts from MSD, Yale University, UC Berkeley, Washington University and University of Toronto, our 200+ team specializes in the R&D, manufacturing, and sales of APIs, formulations, veterinary drugs, intimate health, and personal care products. With RMB 65 million in registered capital, VBIO delivers world-class innovation from our Guangzhou Economic and Technological Development Zone base.

Learn more
about1
R&D Expert Team
Recruited more than
200+
members
about2
Registered Capital
Reaching an amount of
65+
million RMB
about3
Patents
Possessing more than
50+
pieces
材料-(1)
Patents
Serving over
30000000
pigs, cattle and sheep
材料
Factory Area
Covering a space of
100000
㎡
Research&OEM
We are committed to providing our customers with technologically innovative, safe,
极简蓝色点阵网格背景
201801121831103110
VFG600

Long‑acting Recombinant Follitropin Compound Preparation. It significantly improves the oestrus and mating rate as well as the overall conception rate of sows, shortens non‑productive days, and its performance meets or exceeds that of comparable imported products.

201801121832323232
UN015

Class‑I New Veterinary Drug, a recombinant protein produced by genetic engineering and mammalian cell expression. It is applied for estrus induction and batch production management in sows. It features stable quality, high safety, with potency complying with the standards of European Pharmacopoeia.

201801121831513151
UN003
Class‑I New Drug. A recombinant protein produced by genetic engineering and mammalian cell expression. It is applied for oestrus induction and ovulation induction in female livestock, and ovulation promotion in artificial propagation of aquatic animals. It features stable quality and high safety, with potency over 5 times the current domestic standard.
201801121832103210
UNO08
Class‑I New Drug, globally innovative recombinant protein drug manufactured via genetic engineering and mammalian cell expression. It is used for oestrus induction and batch production management in sows, as well as superovulation in cattle and sheep. It boasts a long half‑life, stable quality and high safety.
0929-1
重组GnRH-白细胞毒素融合蛋白
重组GnRH-白细胞毒素融合蛋白
0929-2
WJT202
重组猪IL-29(干扰素入1)融合蛋白，防PEDV+PRRSV
0929-3
VJT305
犬IL-31抗体(特应性皮炎，对标Cytopoint)
0929-4
WJT311
大NGF抗体(骨关节炎疼痛，对标Librela)
Product

All products available as API raw materials or finished formulations. Custom specifications and packaging supported. Veterinary products support OEM/ODM services.

Pregnant Mare Serum Gonadotropin
Pregnant Mare Serum Gonadotropin
Female animals induce estrus and promote follicular development, as well as superovulation during embryo transfer.
Chorionic-Gonadotropin-(Animal)
Human Chorionic Gonadotropin
ART/IVF trigger ovulation, luteal support; Male hypogonadism
白底极简 TB-500 玻璃药瓶
TB-500
白底居中的 BPC-157 透明药瓶
BPC-157
极简透明玻璃替尔泊肽药瓶
Tirzepatide
极简医药西林瓶产品照
Cagrilintide
瑞他鲁肽粉末药瓶展示
Retatrutide
威一配V-OneMate™
V-OneMate™
The first one-time breeding technology
优蕴康V-Follimate®
V-Follimate®
Estrus synchronization & batch production
威乐萌V-Romone®0
V-Romone®
Cat calming & stress relief
6a4dedacfb15482d7a47f4740d6c804
Male Delay Spray
Short-term/Long-term delay
afa3cc486adf295ef4d489e08a6f508
Personal Lubricant
Personal lubrication
Learn more
Application scenarios
VBIO PHARMA Experts in reproduction
3-1
Conference Information | Gather at Leman · New Power in Insemination, Co‑create Innovative Breeding
The 13th Leman China Swine Conference was grandly held in Chengdu, Sichuan from October 25 to 27, 2024. Guangzhou Weisheng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as “Weisheng”) hosted a pre‑conference technical seminar themed “New Power in Insemination, Co‑create Innovative Breeding” on October 24. During the three‑day exhibition from October 25 to 27, Weisheng’s booth welcomed numerous guests and peers. Core competitive products including V‑One‑Mate® and the new product Weiyunbao® drew wide attention for visits and technical exchanges from livestock industry participants.​
新闻3
V‑OneMate® Group Application Case | Boost Production Performance for Batch‑mode Implementation
Batch sow production represents a vital management transformation and an inevitable trend in modern intensive farming. It delivers remarkable long‑term benefits, including higher production efficiency, improved biosecurity and balanced output. Nevertheless, the transition from continuous production to batch production may bring temporary setbacks in key performance indicators such as conception rate and farrowing rate, discouraging some pig farms from making the shift. These challenges can be effectively mitigated through well‑planned batch‑production roll‑out, precise hormone‑based technical application and standardized staff operation management. Such measures help pig farms enhance production performance and achieve a smooth transition during transformation, so as to secure improved economic returns and capture the long‑term dividends brought by batch production.​
新闻
Invitation | VBIO Pharma Invites You to Attend the 16th China Dairy Industry Conference in Xiamen
The 16th China Dairy Industry Conference and 2025 China Dairy Industry Exhibition will grandly open at Xiamen International Conference & Exhibition Center from July 13 to 15, 2025.​
5-1
Gilt Special Topic | V‑OneMate® Achieves a 22.6% Increase in Breeding Conception Rate of Sows under the 21‑day Batch Production Model (South China)
Since the launch of V‑OneMate®, its clinical efficacy has been validated by multi‑round data accumulated from multiple Top30 group‑owned pig farms and large‑scale commercial farms. The product solution can significantly improve the breeding conception rate of sows with statistically‑significant differences. To further expand and accumulate field application cases of V‑OneMate® in large‑scale pig farms, this article presents its performance among gilts at a large‑scale pig farm in South China. The results show that V‑OneMate® delivered a notable improvement in the breeding conception rate of gilts, rising from 65.5% to 88.1%, representing a 22.6% increase. Meanwhile, it reduces reliance on estrus‑detection skills, as well as mating frequency and semen consumption.​
Cooperative Clients
We are committed to providing our customers with technologically innovative, safe,
Overseas
Overseas
China
China
Guangzhou Vbio-pharma
Co.,Ltd
Contact Number
Business Cooperation:+86-16624628010
Reception:+86-16624628010
CompanyAddress
No. 9 Dongcheng 1st Street, Guangzhou Economic & Technological Development Zone, Guangzhou,China


Mail: mindy@vbio-pharma.com
Code：510730
Links
Guangzhou Youhuikang Biological Technology Co.,Ltd. South China Agricultural University
Copyright © VBIO Pharma All Rights Reserved.